When laboratory animals are inoculated intracerebrally with brain homogenates from these patients, they accumulate PrPSc molecules with the same PK resistant core as the inoculated PrP, and develop neurological diseases with different incubation times and neuropathological lesions.4 This evidence concerns the gene PRNP and nervous system disorder.